Cargando…
BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT
A recent approach for limiting production of pro-inflammatory cytokines has been to target bromodomain and extra-terminal (BET) proteins. These epigenetic readers of histone acetylation regulate transcription of genes involved in inflammation, cardiovascular disease, and cancer. Development of BET i...
Autores principales: | Copsel, Sabrina N., Lightbourn, Casey O., Barreras, Henry, Lohse, Ines, Wolf, Dietlinde, Bader, Cameron S., Manov, John, Kale, Brandon J., Shah, Devangi, Brothers, Shaun P., Perez, Victor L., Komanduri, Krishna V., Wahlestedt, Claes, Levy, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353853/ https://www.ncbi.nlm.nih.gov/pubmed/30733722 http://dx.doi.org/10.3389/fimmu.2018.03104 |
Ejemplares similares
-
Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?
por: Copsel, Sabrina N., et al.
Publicado: (2022) -
BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014) -
Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection
por: Lightbourn, Casey O., et al.
Publicado: (2021) -
The promise of CD4(+)FoxP3(+) regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation
por: Copsel, Sabrina, et al.
Publicado: (2019) -
Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010)